Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Hana Lee
U.S. Food and Drug Administration
Poster(s):
(104) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in Germany: A Multinational Study with a Common Protocol Led by FDA
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
(86) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in The U.S., Canada, and Denmark
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
